Cannabis Law Report

AUGUST 26, 2022

Several companies are facilitating the development of this product. More research is still needed to explore this uncharted territory. However, deeper research is needed to better understand its roles. Apart from this, various clinical trials are done for multiple conditions. Alcohol use or alcohol withdrawal.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Key findings from the pre-clinical trial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug. after injection.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1: Bionorica SE BX-1 is an oral solution containing dronabinol, being developed by Bionorica.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

The Cannigma

SEPTEMBER 21, 2021

He also made a point of noting that while the cannabis creams and spray he uses have reduced stiffness and pain in his hands, and have helped him sleep – they do not get him high. The coach supports using cannabis for sports-related injuries, particularly back pain (Wikimedia Commons). Nothing is further from the truth.”.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1 is an oral solution containing dronabinol, being developed by Bionorica. BX-1: Bionorica SE. VSN16R: Canbex Therapeutics.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Cannabis Law Report

DECEMBER 28, 2021

The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., It interacts with different receptors to regulate stress, sleep schedule, pain management, immune system, mood, etc. So, there are huge developments after that.

CBD 52

CBD Clinical Trials Consumption Chronic Pain 52

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

The Cannigma

JUNE 24, 2021

For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.

CBD 75

CBD Microdosing Edibles Sleep 75

CannaMD

NOVEMBER 8, 2019

VA scientists may conduct research on marijuana benefits and risks, and potential for abuse, under regulatory approval. Research suggests that marijuana may work in a number of different ways to decrease PTSD symptoms. VA pharmacies may not fill prescriptions for medical marijuana. You’re Not Alone.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Green Relief

MAY 13, 2018

Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. The patent.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. At the same time, the outlook on cannabis research data is largely positive. Primary sources most frequently used in these reports are peer-reviewed journals or government reports, voices from medical associations or foundations, as well as government and university researchers.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization 128

Legalization Patients Education Dispensary 128